CTSH - Cognizant Technology Solutions

Cognizant provides IT outsourcing, application development, cloud migration, and AI/data analytics services to large enterprise clients across financial services, healthcare, retail, and communications industries. The business model is B2B services with long-term managed services contracts and project-based engagements, typically with Fortune 500 and Global 2000 companies. Annual revenue is approximately $19.7B, with roughly 75% derived from North America and the remainder split between Europe and the rest of world. Delivery is heavily India-based, giving Cognizant a labor-cost arbitrage model that underpins its margin structure.

Past Year Trends

• Cognizant completed the acquisition of Belcan, an engineering R&D services firm serving aerospace and defense clients, for approximately $1.3 billion in mid-2024, adding roughly $650 million in annualized revenue and marking the company's largest deal under CEO Ravi Kumar S. (Bullish)
• Cognizant returned to positive organic constant-currency revenue growth in Q4 2024 at approximately +4.4% YoY, ending a multi-quarter streak of flat-to-declining revenues, driven primarily by large deal ramp-ups in the Financial Services and Healthcare verticals. (Bullish)
• Cognizant's full-year FY2024 revenue of approximately $19.7 billion remained nearly flat in reported USD terms due to currency headwinds and continued softness in discretionary IT spending from large BFSI and Healthcare clients, even as deal bookings improved. (Bearish)

Next Year Trends

• Cognizant faces material headwinds from tightened U.S. H-1B visa policy under the Trump administration, which threatens to raise onsite labor costs for a company that deploys tens of thousands of India-based employees in the U.S. and has limited ability to substitute local hires at equivalent cost within 12 months. (Bearish)
• Conversion of the large-deal TCV pipeline booked in 2024-2025 into recognized revenue represents the primary organic growth catalyst, with management guiding for 3.5-6% constant-currency revenue growth in 2025 contingent on deal ramp velocity in Financial Services and Healthcare accounts. (Bullish)
• Cognizant's Healthcare segment, which represents roughly 27% of revenue and is heavily concentrated in a small number of U.S. managed-care and hospital-system clients, faces spending pressure following disruption at major payers, risking discretionary project deferrals that could drag segment growth below company-average rates. (Bearish)

Red Flags

[Securities Fraud / Investigation] Cognizant entered into a deferred prosecution agreement and paid ~$25 million to resolve DOJ and SEC charges that the company bribed Indian government officials to obtain building permits, in violation of the Foreign Corrupt Practices Act. — U.S. Department of Justice / SEC, February 2019

[Executive Fraud Charges] Former Cognizant President Gordon Coburn and former Chief Legal Officer Steven Schwartz were criminally indicted on FCPA charges for allegedly authorizing and concealing bribe payments to Indian officials. — U.S. Department of Justice, February 2019